Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 9,414 | 8,294 | 8,705 | 7,423 | 7,816 |
| Operating Income | -9,414 | -8,294 | -8,705 | -7,423 | -7,816 |
| Other Income | -8,107 | -1,885 | 1,515 | -3,044 | 4 |
| Pre-tax Income | -17,520 | -10,179 | -7,191 | -10,467 | -7,811 |
| Net Income Continuous | -17,520 | -10,179 | -7,191 | -10,407 | -7,811 |
| Net Income | $-17,520 | $-10,179 | $-7,191 | $-10,407 | $-7,811 |
| EPS Basic Total Ops | -46.55 | -27.03 | -19.22 | -30.33 | -38.44 |
| EPS Basic Continuous Ops | -46.52 | -27.14 | -19.17 | -30.21 | -38.39 |
| EPS Diluted Total Ops | -46.55 | -27.03 | -19.22 | -30.33 | -38.44 |
| EPS Diluted Continuous Ops | -46.52 | -27.14 | -19.17 | -30.21 | -38.39 |
| EBITDA(a) | $-9,372 | $-8,255 | $-8,663 | $-7,384 | $-7,783 |